Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. Among authors: nagao s. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial.
Takahashi Y, Fujiwara H, Yamamoto K, Yamaguchi S, Nagao S, Takano M, Miyamoto M, Hasegawa K, Miwa M, Yasuoka T, Yamashita S, Hirakawa T, Nagai T, Hamada Y, Uno M, Mori-Uchino M, Ohwada M, Mitsuhashi A, Satoh T, Fujiwara K, Suzuki M; GOTIC-VTE Trial Investigators. Takahashi Y, et al. Among authors: nagao s. J Thromb Thrombolysis. 2024 Nov 27. doi: 10.1007/s11239-024-03055-1. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 39602066
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
Rho-associated, coiled-coil-containing protein kinase 2 regulates expression of mineralocorticoid receptor to mediate sodium reabsorption in mice.
Sekiguchi K, Matoba K, Nagai Y, Nagao S, Ohashi S, Mitsuyoshi E, Hayashi T, Kawanami D, Yokota T, Shibata H, Utsunomiya K, Nishimura R. Sekiguchi K, et al. Among authors: nagao s. Biochem Biophys Res Commun. 2024 Dec 3;736:150874. doi: 10.1016/j.bbrc.2024.150874. Epub 2024 Oct 23. Biochem Biophys Res Commun. 2024. PMID: 39467357
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trial.
Ogasawara A, Matsushita H, Tan TZ, Shintani D, Ye J, Nagao S, Demachi-Okamura A, Muraoka D, Kobayashi Y, Kakimi K, Yamaguchi R, Matsuo K, Yamamoto K, Fujiwara K, Huang RY, Tan DSP, Hasegawa K. Ogasawara A, et al. Among authors: nagao s. Gynecol Oncol. 2024 Dec;191:124-131. doi: 10.1016/j.ygyno.2024.09.023. Epub 2024 Oct 15. Gynecol Oncol. 2024. PMID: 39413557 Clinical Trial.
1,139 results